216 related articles for article (PubMed ID: 16523720)
1. [Biological activity and pharmacological prospects of lupane terpenoids: I. Natural lupane derivatives].
Tolstikova TG; Sorokina IV; Tolstikov GA; Tolstikov AG; Flekhter OB
Bioorg Khim; 2006; 32(1):42-55. PubMed ID: 16523720
[TBL] [Abstract][Full Text] [Related]
2. Betulinic Acid and its Derivatives as Potential Antitumor Agents.
Zhang DM; Xu HG; Wang L; Li YJ; Sun PH; Wu XM; Wang GJ; Chen WM; Ye WC
Med Res Rev; 2015 Nov; 35(6):1127-55. PubMed ID: 26032847
[TBL] [Abstract][Full Text] [Related]
3. Triphenylphosphonium Analogues of Betulin and Betulinic Acid with Biological Activity: A Comprehensive Review.
Grymel M; Zawojak M; Adamek J
J Nat Prod; 2019 Jun; 82(6):1719-1730. PubMed ID: 31141361
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, proapoptotic screening, and structure-activity relationships of novel aza-lupane triterpenoids.
Mar AA; Szotek EL; Koohang A; Flavin WP; Eiznhamer DA; Flavin MT; Xu ZQ
Bioorg Med Chem Lett; 2010 Sep; 20(18):5389-93. PubMed ID: 20719505
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and studies of anticancer properties of lupane-type triterpenoid derivatives containing a cisplatin fragment.
Emmerich D; Vanchanagiri K; Baratto LC; Schmidt H; Paschke R
Eur J Med Chem; 2014 Mar; 75():460-6. PubMed ID: 24561674
[TBL] [Abstract][Full Text] [Related]
6. New Pharmacological Opportunities for Betulinic Acid.
Ríos JL; Máñez S
Planta Med; 2018 Jan; 84(1):8-19. PubMed ID: 29202513
[TBL] [Abstract][Full Text] [Related]
7. [Biological activity and pharmacological prospects of lupane terpenoids: II. Semisynthetic lupane derivatives].
Tolstikova TG; Sorokina IV; Tolstikov GA; Tolstikov AG; Flekhter OB
Bioorg Khim; 2006; 32(3):291-307. PubMed ID: 16808172
[TBL] [Abstract][Full Text] [Related]
8. Lupane triterpenoids--betulin and betulinic acid derivatives induce apoptosis in tumor cells.
Kommera H; Kaluđerović GN; Kalbitz J; Paschke R
Invest New Drugs; 2011 Apr; 29(2):266-72. PubMed ID: 19957199
[TBL] [Abstract][Full Text] [Related]
9. A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents.
Baglin I; Mitaine-Offer AC; Nour M; Tan K; Cavé C; Lacaille-Dubois MA
Mini Rev Med Chem; 2003 Sep; 3(6):525-39. PubMed ID: 12871156
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Rhodamine-Conjugated Lupane Type Triterpenes of Enhanced Cytotoxicity.
Denner TC; Heise NV; Hoenke S; Csuk R
Molecules; 2024 May; 29(10):. PubMed ID: 38792206
[TBL] [Abstract][Full Text] [Related]
11. Glycosidation of lupane-type triterpenoids as potent in vitro cytotoxic agents.
Gauthier C; Legault J; Lebrun M; Dufour P; Pichette A
Bioorg Med Chem; 2006 Oct; 14(19):6713-25. PubMed ID: 16787747
[TBL] [Abstract][Full Text] [Related]
12. Betulinic acid: A natural promising anticancer drug, current situation, and future perspectives.
Aswathy M; Vijayan A; Daimary UD; Girisa S; Radhakrishnan KV; Kunnumakkara AB
J Biochem Mol Toxicol; 2022 Dec; 36(12):e23206. PubMed ID: 36124371
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxicity of triterpenoids derived from betulin and betulinic acid via click chemistry.
Shi W; Tang N; Yan WD
J Asian Nat Prod Res; 2015; 17(2):159-69. PubMed ID: 25379995
[TBL] [Abstract][Full Text] [Related]
14. Antileishmanial activity of semisynthetic lupane triterpenoids betulin and betulinic acid derivatives: synergistic effects with miltefosine.
Sousa MC; Varandas R; Santos RC; Santos-Rosa M; Alves V; Salvador JA
PLoS One; 2014; 9(3):e89939. PubMed ID: 24643019
[TBL] [Abstract][Full Text] [Related]
15. A 3D-QSAR Study on Betulinic Acid Derivatives as Anti-Tumor Agents and the Synthesis of Novel Derivatives for Modeling Validation.
Ding W; Zhang S; Zhu M; Wang S; Xu T; Qu H; Yu T; Yan X; Wang Y
Anticancer Agents Med Chem; 2017; 17(4):566-575. PubMed ID: 27658994
[TBL] [Abstract][Full Text] [Related]
16. Natural Product Triterpenoids and Their Semi-Synthetic Derivatives with Potential Anticancer Activity.
Ren Y; Kinghorn AD
Planta Med; 2019 Aug; 85(11-12):802-814. PubMed ID: 30658371
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the divergent activities of betulinic acid via neoglycosylation.
Goff RD; Thorson JS
Org Lett; 2009 Jan; 11(2):461-4. PubMed ID: 19102682
[TBL] [Abstract][Full Text] [Related]
18. Potential use of nanocarriers with pentacyclic triterpenes in cancer treatments.
Valdés K; Morales J; Rodríguez L; Günther G
Nanomedicine (Lond); 2016 Dec; 11(23):3139-3156. PubMed ID: 27809705
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents.
Cui HW; He Y; Wang J; Gao W; Liu T; Qin M; Wang X; Gao C; Wang Y; Liu MY; Yi Z; Qiu WW
Eur J Med Chem; 2015 May; 95():240-8. PubMed ID: 25817774
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of betulinic acid derivatives with activity against human melanoma.
Kim DS; Pezzuto JM; Pisha E
Bioorg Med Chem Lett; 1998 Jul; 8(13):1707-12. PubMed ID: 9873420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
